Advantages

  • Manufacturable in volume, at speed
  • Safe, effective, affordable
  • New variant versions simple and rapid to produce
  • Needle free. Overcomes needle phobia. More amenable for use with children
  • More cost effective, no health care professional required to administer
  • Effective Cross strain protective, valuable for seasonal changes in influenza and for pandemics
  • Long-lasting protection
  • No anti-vector reactivity
  • T-Cell induction
  • More boostable immune responses
  • Lower dose is required, reducing costs and time of manufacture and facilitating storage and logistics issues
  • No cold chain.
  • Lower costs enable LMI Countries to be included immediately
  • No lag time to bank feedstocks & manufacture vaccine lots
  • Disease X ready
  • More effective against SARS-CoV-2 and variants, Influenza, RSV, TB and more